DOLAN CHARLES F
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
MSGE Eyes Strong Q1 Earnings, Potential Re-Rating. Analysts anticipate robust first‑quarter results for Madison Square Garden Entertainment, which could prompt a re‑rating of the stock. The company sits near a neutral RSI and a key support level around $75.96, within its 52‑week range. A positive earnings surprise may lift the share toward its analyst target of $91.62.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Guggenheim lowers Sphere Entertainment price target to $180. Guggenheim has lowered its price target for Sphere Entertainment to $180 while maintaining a Buy rating. This update places the firm's estimate within the broader analyst consensus range of $125 to $200. The stock is currently trading near its 52-week low, reflecting recent market pressure despite the firm's continued positive outlook.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
AMCX noted among media stocks watched after Paramount‑Warner Bros Discovery deal. Retail investors have turned attention to media companies after the announced Paramount and Warner Bros Discovery transaction. AMC Global Media is listed among the stocks being monitored as the deal reshapes the entertainment sector. The heightened focus could influence trading activity, especially as the stock trades near its recent support level.
Transaction History
| MSGS | ▼ Sell | Other | 3,350 | $611K | 3/15/2024 | View on chart |
| MSGE | ▼ Sell | Other | 5,079 | $191K | 3/15/2024 | View on chart |
| SPHR | ▼ Sell | Other | 5,079 | $245K | 3/15/2024 | View on chart |
| MSGE | ▼ Sell | Other | 50,307 | — | 4/20/2023 | View on chart |
| MSGE | ▼ Sell | Other | 1,000 | — | 4/20/2023 | View on chart |
| MSGE | ▼ Sell | Other | 17,773 | — | 4/20/2023 | View on chart |
| AMCX | ▲ Buy | Option Exercise | 7,276 | $0 | 3/9/2023 | View on chart |
| AMCX | ▼ Sell | Tax Withholding | 3,595 | $70K | 3/9/2023 | View on chart |
| AMCX | ▲ Buy | Grant | 16,006 | $0 | 3/9/2022 | View on chart |
| AMCX | ▼ Sell | Tax Withholding | 5,875 | $228K | 3/9/2022 | View on chart |
| AMCX | ▲ Buy | Option Exercise | 3,162 | $0 | 3/9/2022 | View on chart |
| AMCX | ▼ Sell | Tax Withholding | 1,139 | $44K | 3/9/2022 | View on chart |
| AMCX | ▲ Buy | Option Exercise | 7,276 | $0 | 3/9/2022 | View on chart |
| AMCX | ▼ Sell | Tax Withholding | 2,732 | $106K | 3/9/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Knicks' role in Foot Locker's turnaround discussed
Recent coverage examines how the New York Knicks may support Foot Locker's efforts to improve its business performance. This is relevant to Madison Square Garden Sports Corp. because the Knicks are a major asset within the MSGS portfolio. While the news focuses on a partner's strategy, it highlights the broader commercial ecosystem surrounding the team.
Knicks' role in Foot Locker's turnaround discussed. Recent coverage examines how the New York Knicks may support Foot Locker's efforts to improve its business performance. This is relevant to Madison Square Garden Sports Corp. because the Knicks are a major asset within the MSGS portfolio. While the news focuses on a partner's strategy, it highlights the broader commercial ecosystem surrounding the team.